Antiparallel triple-strand architecture for prefibrillar Aβ42 oligomers

Area of Science:

• Biochemistry
• Neuroscience
• Structural Biology

Background:

• Amyloid-beta 42 (Aβ42) oligomers are implicated in Alzheimer disease.
• The precise structures of these toxic oligomers are not well understood due to their transient nature.

Purpose of the Study:

• To determine the atomic-level structure of Aβ42 oligomers.
• To understand the structural basis of Aβ42 oligomer formation and its relation to fibrils.

Main Methods:

• Utilized a fusion construct to stabilize Aβ42 oligomers.
• Employed site-directed spin labeling and electron paramagnetic resonance (EPR) spectroscopy.
• Integrated EPR data with other biophysical information to build an atomic model.

Main Results:

• Established detailed structural restraints for all 42 Aβ42 residues.
• Developed a novel atomic-level model of a stable Aβ42 oligomer.
• Proposed a mechanism for interconversion between toxic oligomers and fibrils involving β-strand rotation.

Conclusions:

• The study provides unprecedented atomic detail of prefibrillar Aβ42 oligomers.
• Insights into oligomer structure and dynamics may enable the design of targeted Alzheimer disease therapeutics.
• Understanding the oligomer-to-fibril transition is key for developing effective treatments.